Raynaud's phenomenon laboratory findings: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Raynaud's phenomenon}} | {{Raynaud's phenomenon}} | ||
'''Editors-In-Chief:''' Asghar Fakhri, M.D., Duane S. Pinto, M.D. and C. Michael Gibson, M.S., M.D. | '''Editors-In-Chief:''' Asghar Fakhri, M.D., Duane S. Pinto, M.D. and [[User:C Michael Gibson|C. Michael Gibson, M.S., M.D.]] | ||
== Overview == | == Overview == | ||
Revision as of 22:20, 21 August 2012
Raynaud's phenomenon Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Raynaud's phenomenon laboratory findings On the Web |
American Roentgen Ray Society Images of Raynaud's phenomenon laboratory findings |
Risk calculators and risk factors for Raynaud's phenomenon laboratory findings |
Editors-In-Chief: Asghar Fakhri, M.D., Duane S. Pinto, M.D. and C. Michael Gibson, M.S., M.D.
Overview
Laboratory Findings
- Labs include:
- CBC with differential
- TSH
- Hepatitis
- Creatine phosphokinase
- ANA
- ESR
- Rheumatoid factor
Autoantibody Testing
- Anti-double stranded DNA and anti - Sm
- Anti - Sjögren's syndrome
- Anti - CREST syndrome
- Anti - ribonucleoprotein
- Anti - Scl 70
- ANCA
References